# Invesco DB Commodity Index Tracking Fund: financial statements, quarterly

DBC · NYSE · CIK 1328237 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dbc.md) · [Financials](/companies/dbc/financials.md) · [Filings](/companies/dbc/filings.md) · [Insiders](/companies/dbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [23.8](/filings/0000950170-24-122592.md) | [23.2 d](/filings/0001193125-26-083563.md) | [18.7](/filings/0000950170-25-067157.md) | [19.2](/filings/0000950170-25-105193.md) | [17.3](/filings/0001193125-25-270307.md) | [14.0 d](/filings/0001193125-26-083563.md) | [11.3](/filings/0001193125-26-209724.md) | [9.9](/filings/0001193125-26-338697.md) | [10.6](/filings/0001193125-25-270307.md) | [9.6 d](/filings/0001193125-26-083563.md) | [8.9](/filings/0001193125-26-209724.md) | [12.9](/filings/0001193125-26-338697.md) |
| Interest expense | $m | [0.1](/filings/0000950170-24-122592.md) | [0.1 d](/filings/0000950170-24-019059.md) | [0.1](/filings/0000950170-24-054964.md) | [0.1](/filings/0000950170-24-092107.md) | [0.1](/filings/0000950170-24-122592.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [188](/filings/0000950170-24-122592.md) | [(150) d](/filings/0001193125-26-083563.md) | [69.0](/filings/0000950170-25-067157.md) | [19.4](/filings/0000950170-25-105193.md) | [(78.2)](/filings/0001193125-25-270307.md) | [12.2 d](/filings/0001193125-26-083563.md) | [69.2](/filings/0001193125-26-209724.md) | [(51.2)](/filings/0001193125-26-338697.md) | [38.4](/filings/0001193125-25-270307.md) | [36.1 d](/filings/0001193125-26-083563.md) | [368](/filings/0001193125-26-209724.md) | [(148)](/filings/0001193125-26-338697.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [9.3](/filings/0001193125-26-083563.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,214](/filings/0000950170-23-060444.md) | [1,701](/filings/0000950170-25-027261.md) | [1,727](/filings/0000950170-24-054964.md) | [1,750](/filings/0000950170-24-092107.md) | [1,431](/filings/0000950170-24-122592.md) | [1,292](/filings/0001193125-26-083563.md) | [1,363](/filings/0000950170-25-067157.md) | [1,232](/filings/0000950170-25-105193.md) | [1,290](/filings/0001193125-25-270307.md) | [1,227](/filings/0001193125-26-338697.md) | [1,717](/filings/0001193125-26-209724.md) | [1,585](/filings/0001193125-26-338697.md) |
| Total liabilities | $m | [36.9](/filings/0000950170-23-060444.md) | [17.7](/filings/0000950170-25-027261.md) | [10.0](/filings/0000950170-24-054964.md) | [9.0](/filings/0000950170-24-092107.md) | [1.2](/filings/0000950170-24-122592.md) | [7.6](/filings/0001193125-26-083563.md) | [3.8](/filings/0000950170-25-067157.md) | [1.7](/filings/0000950170-25-105193.md) | [0.8](/filings/0001193125-25-270307.md) | [3.3](/filings/0001193125-26-338697.md) | [26.6](/filings/0001193125-26-209724.md) | [8.9](/filings/0001193125-26-338697.md) |
| Shareholders' equity | $m | [2,177](/filings/0000950170-24-122592.md) | [1,683](/filings/0001193125-26-083563.md) | [1,717](/filings/0000950170-25-105193.md) | [1,742](/filings/0001193125-25-270307.md) | [1,430](/filings/0001193125-25-270307.md) | [1,284](/filings/0001193125-26-338697.md) | [1,359](/filings/0001193125-26-338697.md) | [1,231](/filings/0001193125-26-338697.md) | [1,289](/filings/0001193125-25-270307.md) | [1,223](/filings/0001193125-26-338697.md) | [1,690](/filings/0001193125-26-338697.md) | [1,576](/filings/0001193125-26-338697.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(33.2) d](/filings/0000950170-24-122592.md) | [343 d](/filings/0001193125-26-083563.md) | [36.2](/filings/0000950170-25-067157.md) | [(5.3) d](/filings/0000950170-25-105193.md) | [233 d](/filings/0001193125-25-270307.md) | [168 d](/filings/0001193125-26-083563.md) | [2.9](/filings/0001193125-26-209724.md) | [73.6 d](/filings/0001193125-26-338697.md) | [(34.6) d](/filings/0001193125-25-270307.md) | [100 d](/filings/0001193125-26-083563.md) | [(101)](/filings/0001193125-26-209724.md) | [(36.6) d](/filings/0001193125-26-338697.md) |
| Dividends paid | $m | not reported | not reported | [0.6](/filings/0000950170-25-067157.md) | [0.0 d](/filings/0000950170-25-105193.md) | [0.0 d](/filings/0001193125-25-270307.md) | [67.5 d](/filings/0001193125-26-083563.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [84.1 d](/filings/0000950170-24-122592.md) | [336 d](/filings/0001193125-26-083563.md) | [114](/filings/0000950170-25-067157.md) | [73.2 d](/filings/0000950170-25-105193.md) | [265 d](/filings/0001193125-25-270307.md) | [110 d](/filings/0001193125-26-083563.md) | [70.8](/filings/0001193125-26-209724.md) | [168 d](/filings/0001193125-26-338697.md) | [37.8 d](/filings/0001193125-25-270307.md) | [86.9 d](/filings/0001193125-26-083563.md) | [96.6](/filings/0001193125-26-209724.md) | [265 d](/filings/0001193125-26-338697.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 59,250,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338697.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.